Inositol Hexaphosphate (IP6) Inhibits Key Events of Cancer Metastasis: I. In Vitro Studies of Adhesion, Migration and Invasion of MDA-MB 231 Human Breast Cancer Cells

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3671-3679

  Tantivejkul, Kwanchanit ^a   Vucenik, Ivana ^a   Shamsuddin, Abulkalam M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cell adhesion; Invasion; Migration; Phytate; Phytic acid

Indexed keywords

COLLAGEN; FIBRONECTIN; LAMININ; PHYTIC ACID; SCLEROPROTEIN; MATRIGEL; PROTEOGLYCAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL MIGRATION; CELL MOTILITY; DOSE RESPONSE; ENZYME ASSAY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKOCYTE MIGRATION; METASTASIS; PRIORITY JOURNAL; ZYMOGRAPHY; BREAST TUMOR; CELL MOTION; DRUG COMBINATION; DRUG EFFECT; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FIBRONECTINS; HUMANS; LAMININ; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHYTIC ACID; PROTEOGLYCANS;

EID: 0344244904     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Shamsuddin AKM: Inositol phosphates have novel anticancer function. J Nutr 125: 725S-732S, 1995.
2. 6: Growth inhibition and differentiation of human mammary cancer cell lines in vivo. Anticancer Res 16: 3287-3292, 1996.
3. Shamsuddin AKM: Anti-cancer function of phytic acid. Int J Food Sci Tech 37: 769-782, 2002.
4. Sakamoto K, Venkatraman G and Shamsuddin AKM: Growth inhibition and differentiation of HT-29 cells in vivo by inositol hexaphosphate (phytic acid). Carcinogenesis 14: 1815-1819, 1993.
5. 1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res 21: 2393-2403, 2001.
6. 6) in breast cancer cells is mediated by increase in p27 and decrease in Rb protein phosphorylation. Proc Am Assoc Cancer Res 41: 338 (#2141), 2000.
7. Singh RP, Agarwal C and Agarwal R: Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cuslin and Rb-related protein-E2F complex. Carcinogensis 24: 555-563, 2003.
8. 6) on human normal and leukaemic haematopoietic cells. Br J Haematol 117: 577-587, 2002.
9. Jenab M and Thompson LU: Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis. Carcinogenesis 21: 1547-1552, 2000.
10. Ferry S, Matsuda M, Yoshida H and Hirata M: Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway. Carcinogenesis 23: 2031-2041, 2002.
11. Huang C, Ma W-Y, Hecht S and Dong Z: Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3′ kinase. Cancer Res 57: 2873-2878, 1997.
12. Zi X, Singh RP and Agarwal R: Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis 21: 2225-2235, 2000.
13. Shamsuddin AM and Ullah A: Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 10: 625-626, 1989.
14. Shamsuddin AM, Ullah A and Chakravarthy A: Inositol and inositol hexaphosphate suppresses cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 10: 1461-1463, 1989.
15. Ullah A and Shamsuddin AKM: Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 11: 2219-2222, 1990.
16. Vucenik I, Sakamoto K, Bansal M and Shamsuddin AM: Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). Cancer Lett 75: 95-101, 1993.
17. Vucenik I, Yang G-Y and Shamsuddin AM: Inositol hexahosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 16: 1055-1058.
18. Vucenik I, Yang G-Y and Shamsuddin AM: Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr Cancer 28: 7-13, 1997.
19. Vucenik I, Kalebic T, Tantivejkul K and Shamsuddin AKM: Novel anticancer function of inositol hexaphosphate: Inhibition of human rhabdomyosarcoma in vivo and in vivo. Anticancer Res 18: 1377-1384, 1998.
20. 6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res 18: 4083-4090, 1998.
21. Vucenik I, Tomazic VJ, Fabian D and Shamsuddin AKM: Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study. Cancer Lett 65: 9-13, 1992.
22. Engers R and Gabbert HE: Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol 126: 682-692, 2000.
23. Cary LA and Guan J-L: Focal adhesion kinase in integrin-mediated signaling. Frontiers in Bioscience 4: d102-113, 1999.
24. Stupack DG and Cheresh DA: Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 115: 3729-3738, 2002.
25. Chen WT and Wang JY: Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann N Y Acad Sci 878: 361-371, 1999.
26. Vihinen P and Kahari VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166, 2002.
27. Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T and Talieri M: Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer 84: 1488-1496, 2001.
28. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas. Anticancer Res 21: 2021-2028, 2001.
29. Lu Z, Jiang G, Blume-Jensen P and Hunter T: Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21: 4016-4031, 2001.
30. Hangan-Steinman D, Ho W-C, Shenoy P, Chan BMC and Morris VL: Differences in phosphatase modulation of α4β1 and α5β1 integrin-mediated adhesion and migration of B16F1 cells. Biochem Cell Biol 77: 409-420, 1999.
31. Shamsuddin AKM and Yang GY: Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 16: 1975-1979, 1995.
32. McCarthy JB, Basara ML, Palm SL, Sas DF and Furcht LT: The role of cell adhesion proteins-laminin and fibronectin-in the movement of malignant and metastatic cells. Cancer Metastasis Rev 4: 125-152, 1985.
33. Sasaki CY and Passaniti A: Identification of anti-invasive but noncytotoxic chemotherapeutic agents using the tetrazolium dye MTT to quantitate viable cells in Matrigel. Biotechniques 24: 1038-1043, 1998.
34. Meredith JJ, Fazeli B and Schwartz M: The extracellular matrix as a cell survival factor. Mol Biol Cell 4: 953-961, 1993.
35. Frisch S and Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994.
36. Chen C, Mrksich M, Huang S, Whitesides G and Ingber D: Geometric control of cell life and death. Science 276: 1425-1428, 1997.
37. Almeida EAC, Ilic D, Han Q, Hauck CR, Jin F, Kawakatsu H, Schlaepfer DD and Damsky CH: Matrix survival signaling: From fibronectin via focal adhesion kinase to c-June NH2-terminal kinase. J Cell Biol 149: 741-754, 2000.
38. Guvakova M and Surmacz E: The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas and Paxillin. Exp Cell Res 251: 244-255, 1999.
39. Small JV: The actin cytoskeleton. Electron Microsc Rev 1: 155-174, 1988.
40. Mitchison TJ and Cramer LP: Actin-based cell motility and cell locomotion. Cell 84: 371-379, 1996.
41. Kubota Y and Ito K: Chemotactic migration of mesencephalic neural crest cells in the mouse. Dev Dyn 217: 170-179, 2000.
42. Woods A and Couchman JR: Syndecan-4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell 5: 183-192, 1994.
43. Oh ES, Woods A and Couchman JR: Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J Biol Chem 272: 8133-8136, 1997.
44. Couchman JR, Vogt S, Lim ST, Lim Y, Oh ES, Prestwich GD, Theibert A, Lee W and Woods A: Regulation of inositol phospholipid binding and signaling through syndecan-4. J Biol Chem 277: 49296-49303, 2002.
45. Clark EA, King WG, Brugge JS, Symons M and Hynes RO: Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 142: 573-586, 1998.
46. Arthur WT and Burridge K: RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 12: 2711-2720, 2001.
47. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P and Yu D: Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-b1 in human breast cancer cells. Oncogene 20: 8066-8074, 2001.
48. Graf E and Eaton J: Anti-oxidant functions of phytic acid. Free Radical Biol & Med 8: 61-69, 1990.
49. Kolanus W and Seed B: Integrins and inside-out signal transduction: converging signals from PKC and PIP3. Current Opinion in Cell Biology 9: 725-731, 1997.
50. Razzini G, Berrie CP, Vignati S, Broggini M, Mascetta G, Brancaccio A and Falasca M: Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. FASEB J 14: 1179-1187, 2000.
51. 6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions. Anticancer Res 23: 3681-3690, 2003.